TABLE 1.
Healthcare resource utilization among hospitalized solid organ transplant recipients with COVID‐19
| Lung a | Kidney b | Liver c | Heart d | All SOTR e | |
|---|---|---|---|---|---|
| Newly admitted, n (%) | 24 | 255 | 47 | 47 | 376 |
| Non‐survivors | 7 (29.2) | 50 (19.7) | 12 (25.5) | 8 (17.0) | 77 (20.5) |
| Survivors f | 17 (70.8) | 205 (80.4) | 35 (74.5) | 39 (83.0) | 299 (79.5) |
| Median age (IQR), years | 63.5 (54.3–68) | 58 (46–66) | 63 (55.5–68) | 56 (48–71.5) | 59 (47–67) |
| ICU, n (%) g | 11 (45.8) | 99 (38.8) | 19 (40.4) | 16 (34.0) | 147 (39.1) |
| Non‐survivors | 6 (85.7) | 40 (80.0) | 7 (58.3) | 5 (62.5) | 58 (79.5) |
| Survivors | 5 (29.4) | 59 (28.9) | 12 (34.3) | 11 (28.2) | 89 (29.8) |
| Mechanical ventilation, n (%) g | 9 (37.5) | 81 (31.9) | 16 (34.0) | 10 (21.3) | 117 (31.1) |
| Non‐survivors | 5 (71.4) | 37 (74.0) | 9 (75.0) | 3 (37.5) | 54 (75.0) |
| Survivors | 4 (23.5) | 44 (21.6) | 7 (20.0) | 7 (18.0) | 63 (21.1) |
| Median hospital LOS, days (IQR) | 9 (4–16.5) | 9 (5–18) | 13.5 (6–20) | 10.5 (5–19) | 10 (5–19) |
| Non‐survivors h | 9 (6–12) | 12 (6–16) | 16 (7–19) | 16 (6.3–23) | 12 (6–18) |
| Survivorsi | 9 (4–20.3) | 9 (5–18.5) | 13 (7–20) | 10 (5–15) | 10 (5–19) |
| Median ICU LOS, days (IQR) | 8.5 (7–12) | 12 (5–20) | 9 (5–15) | 11 (3–26) | 11 (5–19) |
| Non‐survivors j | 9 (8.3–11.3) | 11 (5–14) | 7 (5.5–12) | 5 (5–19) | 9 (5–14.5) |
| Survivors k | 7 (5.5–8.8) | 14 (7–24) | 11 (8–17.3) | 11 (3–25.8) | 13 (5–24) |
| Median duration of ventilation, days (IQR) | 10.5 (4.5–14) | 12 (7–19) | 9 (6–16) | 16 (10–23) | 12 (7–19) |
| Non‐survivors l | 11 (7.5–14.5) | 11 (5–13 | 7 (5.8–9.3) | 15 (14.5–21) | 10.5 (5–14) |
| Survivors m | 9 (4.5–13) | 14 (8–24) | 14 (9–19) | 16 (6–22) | 14 (7.5–23.5) |
Abbreviations: ICU, intensive care unit; IQR, interquartile range; LOS, length of stay; SOTR, solid organ transplant recipients.
Includes 2 heart‐lung recipients.
Includes 6 kidney‐pancreas recipients and 1 kidney‐vascular composite recipient.
Includes 11 liver‐kidney recipients.
Includes 5 heart‐kidney recipients and 1 heart‐kidney‐small bowel recipient.
Includes all lung, kidney, liver, and heart recipients plus 2 small bowel recipients (1 admitted to ICU, neither received mechanical ventilation, both survived) and 1 vascular composite recipient (admitted to ICU, received mechanical ventilation, survived).
Survivors refer to patients alive on day 28 after COVID‐19 diagnosis.
For survivor and non‐survivor groups, percentages refer to percent of all survivors or all non‐survivors for each organ, respectively.
Excludes 1 kidney and 1 liver recipient for whom data were unavailable.
Excludes 2 kidney recipients for whom data were unavailable.
Excludes 1 lung, 8 kidney, and 1 heart recipient for whom data were unavailable.
Excludes 2 kidney and 1 liver recipient for whom data were unavailable.
Excludes 3 kidney and 1 heart recipient for whom data were unavailable.
Excludes 1 kidney and 1 heart recipient for whom data were unavailable.
Parameters for both survivors and non‐survivors are in BOLD.